CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biopharmaceutical company, announced today that Dr. Spyridon "Spyros" Papapetropoulos has joined as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Papapetropoulos will lead Cavion’s research and development organization to advance therapies based on the company’s T-type calcium channel (Cav3) platform.Read More
CBIC’s Annual Holiday Party to Toast the Town
‘Tis the season to celebrate. Join CBIC, VA Bio and UVA’s Licensing and Ventures Group at our annual holiday party on December 17th. We’re celebrating the accomplishments of local entrepreneurs and technology companies who have made 2015 a triumphant year for the Charlottesville tech community.